Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pKa fluorinated fentanyl analogs, FF3 and NFEPP

IF 4.6 2区 医学 Q1 NEUROSCIENCES
Shelley R. Edwards , Bruce E. Blough , Kristian Cowart , Grace H. Howell , Aaron A. Araujo , Jacob P. Haskell , Sally L. Huskinson , James K. Rowlett , Marcus F. Brackeen , Kevin B. Freeman
{"title":"Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pKa fluorinated fentanyl analogs, FF3 and NFEPP","authors":"Shelley R. Edwards ,&nbsp;Bruce E. Blough ,&nbsp;Kristian Cowart ,&nbsp;Grace H. Howell ,&nbsp;Aaron A. Araujo ,&nbsp;Jacob P. Haskell ,&nbsp;Sally L. Huskinson ,&nbsp;James K. Rowlett ,&nbsp;Marcus F. Brackeen ,&nbsp;Kevin B. Freeman","doi":"10.1016/j.neuropharm.2024.110002","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale</h3><p>Recent studies report that fentanyl analogs with relatively low pK<sub>a</sub> values produce antinociception in rodents without other mu opioid-typical side effects due to the restriction of their activity to injured tissue with relatively low pH values. However, it is unclear if and to what degree these compounds may produce mu opioid-typical side effects (respiratory depression, reinforcing effects) at doses higher than those required to produce antinociception.</p></div><div><h3>Objectives</h3><p>The present study compared the inflammatory antinociceptive, respiratory-depressant, and reinforcing effects of fentanyl and two analogs of intermediate (FF3) and low (NFEPP) pK<sub>a</sub> values in terms of potency and efficacy in male and female Sprague-Dawley rats.</p></div><div><h3>Methods</h3><p>Nociception was produced by administration of Complete Freund's Adjuvant into the hind paw of subjects, and antinociception was measured using an electronic Von Frey test. Respiratory depression was measured using whole-body plethysmography. Reinforcing effects were measured in self-administration using a progressive-ratio schedule of reinforcement. The dose ranges tested for each drug encompassed no effect to maximal effects.</p></div><div><h3>Results</h3><p>All compounds produced full effects in all measures but varied in potency. FF3 and fentanyl were equipotent in antinociception and self-administration, but FF3 was less potent than fentanyl in respiratory depression. NFEPP was less potent than fentanyl in every measure. The magnitude of potency difference between antinociception and other effects was greater for FF3 than for NFEPP or fentanyl, indicating that FF3 had the widest margin of safety when relating antinociception to respiratory-depressant and reinforcing effects.</p></div><div><h3>Conclusions</h3><p>Low pK<sub>a</sub> fentanyl analogs possess potential as safer analgesics, but determining the optimal degree of difference for pK<sub>a</sub> relative to fentanyl will require further study due to some differences between the current results and findings from prior work with these analogs.</p></div>","PeriodicalId":19139,"journal":{"name":"Neuropharmacology","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0028390824001710","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale

Recent studies report that fentanyl analogs with relatively low pKa values produce antinociception in rodents without other mu opioid-typical side effects due to the restriction of their activity to injured tissue with relatively low pH values. However, it is unclear if and to what degree these compounds may produce mu opioid-typical side effects (respiratory depression, reinforcing effects) at doses higher than those required to produce antinociception.

Objectives

The present study compared the inflammatory antinociceptive, respiratory-depressant, and reinforcing effects of fentanyl and two analogs of intermediate (FF3) and low (NFEPP) pKa values in terms of potency and efficacy in male and female Sprague-Dawley rats.

Methods

Nociception was produced by administration of Complete Freund's Adjuvant into the hind paw of subjects, and antinociception was measured using an electronic Von Frey test. Respiratory depression was measured using whole-body plethysmography. Reinforcing effects were measured in self-administration using a progressive-ratio schedule of reinforcement. The dose ranges tested for each drug encompassed no effect to maximal effects.

Results

All compounds produced full effects in all measures but varied in potency. FF3 and fentanyl were equipotent in antinociception and self-administration, but FF3 was less potent than fentanyl in respiratory depression. NFEPP was less potent than fentanyl in every measure. The magnitude of potency difference between antinociception and other effects was greater for FF3 than for NFEPP or fentanyl, indicating that FF3 had the widest margin of safety when relating antinociception to respiratory-depressant and reinforcing effects.

Conclusions

Low pKa fentanyl analogs possess potential as safer analgesics, but determining the optimal degree of difference for pKa relative to fentanyl will require further study due to some differences between the current results and findings from prior work with these analogs.

Abstract Image

评估低 pKa 氟芬太尼类似物 FF3 和 NFEPP 的抗镇痛、呼吸抑制和强化作用。
理由最近的研究报告称,pKa 值相对较低的芬太尼类似物可在啮齿动物体内产生抗镇痛作用,但由于其活性仅限于 pH 值相对较低的受伤组织,因此不会产生其他μ阿片典型副作用。然而,目前还不清楚这些化合物在剂量高于产生抗痛作用所需的剂量时是否以及在多大程度上会产生μ阿片典型副作用(呼吸抑制、强化作用):本研究比较了芬太尼和两种中等 pKa 值(FF3)和低 pKa 值(NFEPP)类似物在雄性和雌性 Sprague-Dawley 大鼠体内的炎症抗痛、呼吸抑制和强化作用的效力和疗效:向受试者的后爪注射完全弗氏佐剂以产生痛觉,并使用电子冯弗氏试验测量抗痛觉。使用全身胸透测量呼吸抑制。在自我给药过程中,使用渐进比例强化表测量强化效果。每种药物的测试剂量范围包括无效应到最大效应:结果:所有化合物在所有测量中都产生了充分效应,但效力各不相同。FF3 和芬太尼在抗痛觉和自我给药方面的作用相当,但 FF3 在呼吸抑制方面的作用不如芬太尼。NFEPP 在所有方面的效力都低于芬太尼。与 NFEPP 或芬太尼相比,FF3 在抗镇痛和其他效应之间的效力差异幅度更大,这表明在将抗镇痛与呼吸抑制和强化效应联系起来时,FF3 的安全系数最大:低 pKa 芬太尼类似物具有作为更安全镇痛药的潜力,但由于目前的研究结果与之前使用这些类似物的研究结果之间存在一些差异,因此确定相对于芬太尼的 pKa 的最佳差异程度还需要进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuropharmacology
Neuropharmacology 医学-神经科学
CiteScore
10.00
自引率
4.30%
发文量
288
审稿时长
45 days
期刊介绍: Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信